摘要
目的观察应用欣普贝生在妊娠期高血压疾病孕妇引产中的临床疗效。方法选取我院2013年6-12月门诊收治的178例妊娠期高血压疾病引产孕妇做为研究对象。按照入院顺序依据引产药物使用情况分为观察组90例与对照组88例,观察组孕妇应用欣普贝生引产,对照组孕妇应用缩宫素引产。对比不同药物应用于孕妇引产的临床效果及临床指标变化。结果观察组孕妇的引产总有效率优于对照组,差异有统计学意义(P〈0.05)。对照组孕妇用药后血压显著升高,相比观察组差异有统计学意义(P〈0.05)。观察组孕妇的新生儿Apgar评分相比对照组,差异无统计学意义(P〉0.05)。结论应用欣普贝生在妊娠期高血压疾病孕妇引产中的临床效果显著,安全有效的促进妊高征孕妇宫颈成熟并减少产妇生产时间。
Objective To observe the clinical efficacy of the application of propess in the pregnant women with gestational hypertension receiving induced labor. Methods 178 pregnant women with gestational hypertension receiving induced labor who were treated in our hospital from June 2013 to December 2013 were selected as the study subjects. The pregnant patients were divided into the observation group with 90 women and the control group with 88 women according to the admission order and the usage of induced labor drugs. The observation group used propess for labor induction and the control group used pitocin for labor induction. The clinical effects and clinical indicators of using different drugs for labor induction were compared. Results The total effective rate of the observation group was better than that of the control group, with statistically significant difference (P 〈 0.05). After medication, the blood pressure of the control group increased obviously, which was significantly different from that of the observation group (P 〈 0.05). The neonates' Apgar score of the observation group was different from that of the control group, with no statistically significant difference (P 〉 0.05). Conclusion In the treatment of pregnant women with gestational hypertension receiving induced labor, thezapplication of propess shows remarkable clinical effects, promotes the cervical ripening safely and effectively, and reduces the delivery time.
出处
《中国医药科学》
2014年第12期59-61,共3页
China Medicine And Pharmacy
关键词
欣普贝生
地诺前列酮栓
妊娠期高血压疾病
引产
Propess
Dinoprostone suppository
Gestational hypertension
Induced abortion